Lantheus Holdings’ incoming CEO Brian Markison [Image courtesy of Lantheus]
Radiopharmaceutical-focused Lantheus Holdings (NASDAQ: LNTH) announced today that current board chair and industry veteran Brian Markison will become the company’s CEO, effective March 1.Markison succeeds Mary Anne Heino, who is retiring from Lantheus’ corner office after leading the company for nine years. Heino will serve as board chair after March 1. Board member Julie McHugh will become lead independent director effective immediately.
“Brian is perfectly suited to lead Lantheus as the company enters its next growth phase. He has held the chair role for more than 10 years and in that role has overseen company strategy. He knows our exceptional executive team well and brings decades of leadership experience as the CEO of public companies with development, commercialization and manufacturing expertise, includin…